[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …
WD Travis, E Brambilla, M Noguchi… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society …
WD Travis, E Brambilla, M Noguchi… - … of Pathology and …, 2013 - meridian.allenpress.com
A new lung adenocarcinoma classification has been published by the International
Association for the Study of Lung Cancer, the American Thoracic Society, and the European …
Association for the Study of Lung Cancer, the American Thoracic Society, and the European …
Natural history of stage I non-small cell lung cancer: implications for early detection
Background: Concern has been raised that early detection of lung cancer may lead to the
treatment of clinically indolent cancers. No population-based study has examined the …
treatment of clinically indolent cancers. No population-based study has examined the …
[HTML][HTML] The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review
Introduction The importance of non-small cell lung cancer (NSCLC) histologic subtype has
increased during the last few decades because of an unprecedented shift in epidemiology …
increased during the last few decades because of an unprecedented shift in epidemiology …
[HTML][HTML] Adenocarcinoma of the lung in childhood and adolescence: a systematic review
BWR Balzer, C Loo, CR Lewis, TN Trahair… - Journal of Thoracic …, 2018 - Elsevier
Primary lung cancer is extremely rare in children. It often presents with metastatic disease
and carries a poor prognosis. Adenocarcinoma is the most common type of bronchogenic …
and carries a poor prognosis. Adenocarcinoma is the most common type of bronchogenic …
Cancer of the lung: Non–small cell lung cancer and small cell lung cancer
LH Araujo, L Horn, RE Merritt, K Shilo… - Abeloff's clinical …, 2020 - Elsevier
Lung cancer is a highly incident disease, and the major cause of cancer death worldwide.
Trends in lung cancer incidence and mortality follow an epidemiological link to the history of …
Trends in lung cancer incidence and mortality follow an epidemiological link to the history of …
Lung cancer incidence in the Arab league countries: risk factors and control
Although lung cancer incidence rates and mortalities are still low in the Arab world as
compared to Europe orUSA, they is gradually increasing in the region. Furthermore, there is …
compared to Europe orUSA, they is gradually increasing in the region. Furthermore, there is …
[HTML][HTML] Enhancing Cancer Treatment Through Combined Approaches: Photodynamic Therapy in Concert with Other Modalities
G Hong, JE Chang - Pharmaceutics, 2024 - mdpi.com
This review explores the role of photodynamic therapy (PDT) as an adjunctive treatment for
cancers, with a focus on its potential to enhance the effects of established therapies like …
cancers, with a focus on its potential to enhance the effects of established therapies like …
Human complement factor H is a novel diagnostic marker for lung adenocarcinoma
Human complement factor H (CFH), a central complement control protein, is a member of
the regulators of complement activation family. Recent studies suggested that CFH may play …
the regulators of complement activation family. Recent studies suggested that CFH may play …
Lung cancer in never smokers
P Yang - Seminars in respiratory and critical care medicine, 2011 - thieme-connect.com
Lung cancer in never smokers (LCINS) has lately been recognized as a unique disease
based on rapidly gained knowledge from genomic changes to treatment responses. The …
based on rapidly gained knowledge from genomic changes to treatment responses. The …